Cargando…
The lung in amyloidosis
Amyloidosis is a disorder caused by misfolding of autologous protein and its extracellular deposition as fibrils, resulting in vital organ dysfunction and eventually death. Pulmonary amyloidosis may be localised or part of systemic amyloidosis. Pulmonary interstitial amyloidosis is symptomatic only...
Autores principales: | Milani, Paolo, Basset, Marco, Russo, Francesca, Foli, Andrea, Palladini, Giovanni, Merlini, Giampaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488920/ https://www.ncbi.nlm.nih.gov/pubmed/28877975 http://dx.doi.org/10.1183/16000617.0046-2017 |
Ejemplares similares
-
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
por: Milani, Paolo, et al.
Publicado: (2020) -
Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018) -
Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017) -
PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023) -
Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)